Besunyen Holdings Company Limited Stock

Equities

926

KYG107051123

Food Processing

Delayed Hong Kong S.E. 10:21:13 2024-05-07 pm EDT 5-day change 1st Jan Change
2.65 HKD +1.53% Intraday chart for Besunyen Holdings Company Limited -7.99% -10.17%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site

Financials

Sales 2022 943M 131M 1.02B Sales 2023 543M 75.16M 588M Capitalization 328M 45.39M 355M
Net income 2022 -99M -13.71M -107M Net income 2023 -299M -41.39M -324M EV / Sales 2022 0.01 x
Net cash position 2022 243M 33.66M 263M Net cash position 2023 248M 34.29M 268M EV / Sales 2023 0.15 x
P/E ratio 2022
-1.19 x
P/E ratio 2023
-1.1 x
Employees 179
Yield 2022 *
-
Yield 2023
-
Free-Float 40.09%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.92%
1 week-7.64%
Current month-15.56%
1 month-19.64%
6 months-28.69%
Current year-9.83%
More quotes
1 week
2.60
Extreme 2.6
3.16
1 month
2.60
Extreme 2.6
4.12
Current year
2.46
Extreme 2.46
4.12
1 year
2.46
Extreme 2.46
5.30
3 years
1.65
Extreme 1.65
19.60
5 years
1.65
Extreme 1.65
19.60
10 years
1.65
Extreme 1.65
68.00
More quotes
Managers TitleAgeSince
Founder 56 09-08-04
Chief Executive Officer 58 09-08-04
Director of Finance/CFO 59 00-06-30
Members of the board TitleAgeSince
Director/Board Member 56 23-10-30
Director/Board Member 58 16-09-30
Chief Executive Officer 58 09-08-04
More insiders
Date Price Change Volume
24-05-07 2.65 +1.53% 25 000
24-05-07 2.61 -3.69% 142,000
24-05-06 2.71 -1.81% 174,150
24-05-03 2.76 -4.17% 133,000
24-05-02 2.88 -8.57% 235,750

Delayed Quote Hong Kong S.E., May 07, 2024 at 09:56 pm EDT

More quotes
Besunyen Holdings Company Limited is a Hong Kong-based investment holding company principally engaged in the research, development, manufacture, marketing and sales of therapeutic tea. The Company operates through two segments. Tea Products segment is engaged in production and sales of Besunyen detox tea, Besunyen slimming tea and other tea products, including herbal tea products, among others. Slimming Medicine segment is engaged in the sales of slimming medicines. Its main products include Orlistat slimming medicines. The Company operates businesses in China.
More about the company

Annual profits - Rate of surprise

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW